• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内脂肪堆积受 PNPLA3 基因中 rs738409 变异与饮食中欧米伽 6/欧米伽 3 PUFA 摄入的相互作用调节。

Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake.

机构信息

Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States of America.

出版信息

PLoS One. 2012;7(5):e37827. doi: 10.1371/journal.pone.0037827. Epub 2012 May 21.

DOI:10.1371/journal.pone.0037827
PMID:22629460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3357343/
Abstract

BACKGROUND

A single nucleotide polymorphism (SNP), the rs738409, in the patatin like phospholipase 3 gene (PNPLA3) has been recently associated with increased hepatic steatosis and ALT levels in adults and children. Given the potential role of PNPLA3 in fatty liver development, we aimed to explore whether the influence of PNPLA3 genotype on hepatic fat in obese youth might be modulated by dietary factors such as essential omega polyunsaturated fatty acids (PUFA) intake.

MATERIALS AND METHODS

We studied 127 children and adolescents (56 boys, 71 girls; 58 Caucasians; 30 African Americans and 39 Hispanics; mean age 14.7±3.3; mean BMI 30.7±7.2). The dietary composition was assessed by the Nutrition Data System for Research (NDS-R version 2011). The patients underwent a MRI study to assess the liver fat content (HFF%), ALT measurement and the genotyping of the rs738409 SNP by automatic sequencing.

RESULTS

As previously observed, HFF% and ALT levels varied according to the genotype in each ethnicity. ALT levels and HFF% were significantly influenced by the interaction between genotype and omega-6/omega-3 PUFA ratio (n-6/n-3), p = 0.003 and p = 0.002, respectively. HFF% and ALT levels were, in fact, related to the n-6/n-3 consumption only in subjects homozygote for the G allele of the rs738409 (r2 = 0.45, p =  0.001 and r2 = 0.40, p = 0.006, respectively).

CONCLUSIONS

These findings suggest that the association of a high dietary n-6/n-3 PUFA with fatty liver and liver damage in obese youths may be driven by a predisposing genotype.

摘要

背景

最近的研究表明,载脂蛋白样磷脂酶 3 基因(PNPLA3)中的单核苷酸多态性(SNP)rs738409 与成年人和儿童的肝脂肪变性和 ALT 水平升高有关。鉴于 PNPLA3 在脂肪肝发展中的潜在作用,我们旨在探讨 PNPLA3 基因型对肥胖青少年肝脏脂肪的影响是否可能受到饮食因素的调节,如必需的欧米伽多不饱和脂肪酸(PUFA)的摄入。

材料和方法

我们研究了 127 名儿童和青少年(56 名男孩,71 名女孩;58 名白种人;30 名非裔美国人,39 名西班牙裔;平均年龄 14.7±3.3;平均 BMI 30.7±7.2)。饮食组成通过营养数据系统进行评估(NDS-R 版本 2011)。对患者进行 MRI 研究以评估肝脂肪含量(HFF%)、ALT 测量和 rs738409 SNP 的自动测序。

结果

正如之前观察到的,HFF%和 ALT 水平根据每种族的基因型而变化。ALT 水平和 HFF%受到基因型与 ω-6/ω-3 PUFA 比值(n-6/n-3)之间相互作用的显著影响,p=0.003 和 p=0.002。事实上,只有在 rs738409 的 G 等位基因纯合子的受试者中,HFF%和 ALT 水平才与 n-6/n-3 的消耗有关(r2=0.45,p=0.001 和 r2=0.40,p=0.006)。

结论

这些发现表明,富含 n-6/n-3 PUFA 的饮食与肥胖青少年的脂肪肝和肝损伤之间的关联可能是由易感基因型驱动的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3357343/e993e0118dbc/pone.0037827.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3357343/1a28655e746d/pone.0037827.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3357343/e993e0118dbc/pone.0037827.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3357343/1a28655e746d/pone.0037827.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3357343/e993e0118dbc/pone.0037827.g002.jpg

相似文献

1
Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake.肝内脂肪堆积受 PNPLA3 基因中 rs738409 变异与饮食中欧米伽 6/欧米伽 3 PUFA 摄入的相互作用调节。
PLoS One. 2012;7(5):e37827. doi: 10.1371/journal.pone.0037827. Epub 2012 May 21.
2
A Low ω-6 to ω-3 PUFA Ratio (n-6:n-3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth.低 ω-6 至 ω-3 多不饱和脂肪酸(n-6:n-3 PUFA)比例饮食治疗肥胖青少年脂肪肝。
J Nutr. 2020 Sep 1;150(9):2314-2321. doi: 10.1093/jn/nxaa183.
3
A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.载脂蛋白 L3 基因(PNPLA3)中的常见变异与肥胖儿童和青少年的脂肪肝疾病有关。
Hepatology. 2010 Oct;52(4):1281-90. doi: 10.1002/hep.23832.
4
Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption.超重西班牙裔青少年肝脏脂肪增加受 PNPLA3 基因变异与高膳食碳水化合物和糖摄入相互作用影响。
Am J Clin Nutr. 2010 Dec;92(6):1522-7. doi: 10.3945/ajcn.2010.30185. Epub 2010 Oct 20.
5
The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants.肥胖儿童和青少年肝内脂肪含量与肝损伤的关系:种族、胰岛素抵抗和常见基因变异的影响。
Diabetes Care. 2013 May;36(5):1353-60. doi: 10.2337/dc12-1791. Epub 2012 Dec 28.
6
Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.葡萄糖激酶调节蛋白(GCKR)基因变异与肥胖儿童和青少年的脂肪肝有关。
Hepatology. 2012 Mar;55(3):781-9. doi: 10.1002/hep.24806. Epub 2011 Dec 18.
7
PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.PNPLA3 基因与内脏脂肪组织体积的相互作用与脂肪性肝病的发病机制:美国国立卫生研究院家族心脏研究。
Int J Obes (Lond). 2013 Mar;37(3):432-8. doi: 10.1038/ijo.2012.65. Epub 2012 May 1.
8
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.载脂蛋白基因 3 上 rs738409 多态性与肝损伤及非酒精性脂肪性肝病的发生相关。
BMC Med Genet. 2010 Dec 22;11:172. doi: 10.1186/1471-2350-11-172.
9
Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.肝移植受者中 patatin 样磷脂酶结构域蛋白 3 rs738409-G 是移植肝脂肪变性的危险因素。
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1667-72. doi: 10.1016/j.cgh.2013.06.025. Epub 2013 Jul 18.
10
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.载脂蛋白样磷脂酶域蛋白 3 I148M 多态性与慢性丙型肝炎肝脂肪变和肝损伤
Hepatology. 2011 Mar;53(3):791-9. doi: 10.1002/hep.24123. Epub 2011 Feb 11.

引用本文的文献

1
Assessment of dietary, genetic and metabolic factors in South Indian adolescents with metabolic dysfunction-associated steatotic liver disease: a case-control study protocol.南印度患有代谢功能障碍相关脂肪性肝病的青少年的饮食、遗传和代谢因素评估:一项病例对照研究方案
BMJ Paediatr Open. 2025 Mar 24;9(1):e003138. doi: 10.1136/bmjpo-2024-003138.
2
PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease.PNPLA3 I148M与环境触发因素相互作用导致人类疾病。
Liver Int. 2025 Mar;45(3):e16106. doi: 10.1111/liv.16106. Epub 2024 Nov 19.
3
Integrating PNPLA3 into clinical risk prediction.

本文引用的文献

1
PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis.载脂蛋白 L3 在人肝细胞中受葡萄糖调控,其 I148M 突变可减缓甘油三酯水解。
Am J Physiol Endocrinol Metab. 2012 May 15;302(9):E1063-9. doi: 10.1152/ajpendo.00125.2011. Epub 2012 Feb 14.
2
The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.载脂蛋白 PLA3 基因变异与儿童肥胖症中肝脏酶的相关性是由与腹部脂肪的相互作用所驱动的。
PLoS One. 2011;6(11):e27933. doi: 10.1371/journal.pone.0027933. Epub 2011 Nov 28.
3
Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.
将PNPLA3纳入临床风险预测。
Liver Int. 2025 Mar;45(3):e16103. doi: 10.1111/liv.16103. Epub 2024 Sep 16.
4
Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine.肠道微生物、饮食和遗传作为代谢性肝病的驱动因素:一篇综述性叙述,概述了对精准医学的影响。
J Nutr Biochem. 2024 Nov;133:109704. doi: 10.1016/j.jnutbio.2024.109704. Epub 2024 Jul 17.
5
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort.遗传风险加剧了基于人群队列的肝脂肪变性、炎症和纤维化的饮食效应。
J Hepatol. 2024 Sep;81(3):379-388. doi: 10.1016/j.jhep.2024.03.045. Epub 2024 Apr 4.
6
High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study.多中心横断面研究显示,载脂蛋白 PNPLA3 多态性人群中,大量摄入红色肉类与非酒精性脂肪性肝病相关。
Eur J Clin Nutr. 2024 May;78(5):442-448. doi: 10.1038/s41430-024-01416-w. Epub 2024 Feb 26.
7
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?儿童肥胖中的代谢功能障碍相关脂肪性肝病(MAFLD)与甲状腺功能:恶性循环?
Children (Basel). 2024 Feb 15;11(2):244. doi: 10.3390/children11020244.
8
Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity.坚持传统的墨西哥饮食与超重或肥胖的美国出生的墨西哥裔西班牙人肝脂肪变性降低有关。
Nutrients. 2023 Dec 2;15(23):4997. doi: 10.3390/nu15234997.
9
Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review.膳食模式、食物和营养素改善非酒精性脂肪性肝病:范围综述。
Nutrients. 2023 Sep 14;15(18):3987. doi: 10.3390/nu15183987.
10
Towards precision medicine in non-alcoholic fatty liver disease.迈向非酒精性脂肪性肝病的精准医学
Rev Endocr Metab Disord. 2023 Oct;24(5):885-899. doi: 10.1007/s11154-023-09820-6. Epub 2023 Jul 21.
葡萄糖激酶调节蛋白(GCKR)基因变异与肥胖儿童和青少年的脂肪肝有关。
Hepatology. 2012 Mar;55(3):781-9. doi: 10.1002/hep.24806. Epub 2011 Dec 18.
4
Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.ω-3 脂肪酸与心血管疾病:对危险因素、分子途径和临床事件的影响。
J Am Coll Cardiol. 2011 Nov 8;58(20):2047-67. doi: 10.1016/j.jacc.2011.06.063.
5
Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis.ω-3 补充剂与非酒精性脂肪性肝病:系统评价和荟萃分析。
J Hepatol. 2012 Apr;56(4):944-51. doi: 10.1016/j.jhep.2011.08.018. Epub 2011 Oct 21.
6
Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease.表达和鉴定与非酒精性脂肪性肝病相关的 PNPLA3 蛋白同工型(I148M)。
J Biol Chem. 2011 Oct 28;286(43):37085-93. doi: 10.1074/jbc.M111.290114. Epub 2011 Aug 30.
7
T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease.T1 加权双回波 MRI 用于儿科非酒精性脂肪性肝病的脂肪定量。
World J Gastroenterol. 2011 Jul 7;17(25):3012-9. doi: 10.3748/wjg.v17.i25.3012.
8
Why and How Meet n-3 PUFA Dietary Recommendations?为什么要满足 n-3 PUFA 的膳食推荐量?
Gastroenterol Res Pract. 2011;2011:364040. doi: 10.1155/2011/364040. Epub 2010 Dec 8.
9
Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.PNPLA3/Adiponutrin 基因缺失的小鼠不会导致脂肪肝或代谢综合征。
J Lipid Res. 2011 Feb;52(2):318-29. doi: 10.1194/jlr.M011205. Epub 2010 Nov 9.
10
Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption.超重西班牙裔青少年肝脏脂肪增加受 PNPLA3 基因变异与高膳食碳水化合物和糖摄入相互作用影响。
Am J Clin Nutr. 2010 Dec;92(6):1522-7. doi: 10.3945/ajcn.2010.30185. Epub 2010 Oct 20.